An Immune Checkpoint-Related Gene Signature for Predicting Survival of Pediatric Acute Myeloid Leukemia

Table 2

Multivariate analysis of AML patients' OS identified independently prognostic factors in TARGET cohort.

	Multivariate analysis
	HR	95%CI	value
Gender	0.601	0.367–0.984	0.0432
WBC at diagnosis	1.001	0.585–1.711	0.9986
Bone marrow leukemic blast percentage	1.082	0.615–1.904	0.7829
CNS disease	1.774	0.693–4.541	0.2315
Age at diagnosis	1.044	1.001–1.089	0.0421
Risk score	1.914	1.366–2.682	0.0001